ID   DEMI
AC   CVCL_A1YM
DR   Wikidata; Q105506737
RX   PubMed=19276180;
RX   PubMed=24443327;
CC   Group: Cancer stem cell line.
CC   Doubling time: 56.5 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=24443327; DOI=10.1002/ijc.28680;
RA   Vecchio, Donatella
RA   Daga, Antonio
RA   Carra, Elisa
RA   Marubbi, Daniela
RA   Baio, Gabriella
RA   Neumaier, Carlo E.
RA   Vagge, Stefano
RA   Corvo, Renzo
RA   Brisigotti, Maria Pia
RA   Ravetti, Jean Louis
RA   Zunino, Annalisa
RA   Poggi, Alessandro
RA   Mascelli, Samantha
RA   Raso, Alessandro
RA   Frosina, Guido
RT   "Predictability, efficacy and safety of radiosensitization of
RT   glioblastoma-initiating cells by the ATM inhibitor KU-60019.";
RL   Int. J. Cancer 135:479-491(2014).
//
RX   PubMed=19276180; DOI=10.1158/1541-7786.MCR-08-0409;
RA   Ropolo, Monica
RA   Daga, Antonio
RA   Griffero, Fabrizio
RA   Foresta, Mara
RA   Casartelli, Gianluigi
RA   Zunino, Annalisa
RA   Poggi, Alessandro
RA   Cappelli, Enrico
RA   Zona, Gianluigi
RA   Spaziante, Renato
RA   Corte, Giorgio
RA   Frosina, Guido
RT   "Comparative analysis of DNA repair in stem and nonstem glioma cell
RT   cultures.";
RL   Mol. Cancer Res. 7:383-392(2009).
//